Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    " February 05, 2012":" March 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 05, 2012":" March 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Medical Marijuana Use in HIV+ Patients: Probability Survey
Condition: HIV Positive
Intervention:
2 Completed Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, emtricitabine, maraviroc;   Drug: Tenofovir, emtricitabine, lopinavir/r
3 Completed Assessing the Safety of Dapivirine Gel and Film Formulations
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Film;   Drug: Dapivirine Vaginal Gel
4 Active, not recruiting Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women
Condition: HIV Infections
Intervention: Drug: Placebo Vaginal Ring
5 Active, not recruiting Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Conditions: HIV Positive;   Marijuana Smoking
Intervention:
6 Completed Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs
Condition: HIV Infection
Intervention: Drug: stop statin and switch to an antiretroviral drug with less impact on lipid metabolism
7 Recruiting Testing and Linkage to Care for Injecting Drug Users in Kenya
Condition: HIV Infection
Intervention: Behavioral: Point of Care CD4 count and peer case management
8 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Intervention: Biological: VRC-HIVADV014-00-VP Vaccine
9 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA009-00-VP;   Biological: Placebo vaccine
10 Completed Fetal HIV Transmission Risk and Duration of Membrane Rupture
Conditions: Human Immunodeficiency Virus;   HIV
Intervention:
11 Completed Preference of Genetic Polymorphism and Pharmacokinetics
Condition: HIV
Intervention:
12 Active, not recruiting Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa
Condition: HIV Prevention
Interventions: Other: Testing and Counseling;   Behavioral: Brief Motivational Interview (BMI);   Behavioral: Integrated Family and Cognitive Behavioral Therapy
13 Completed
Has Results
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
Condition: HIV
Interventions: Drug: Lisinopril;   Drug: Placebo
14 Active, not recruiting Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
Conditions: HCV Coinfection;   HIV Infection
Intervention: Drug: Nitazoxanide
15 Active, not recruiting Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Condition: HIV
Intervention: Genetic: SB-728-T
16 Terminated Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
Condition: HIV
Interventions: Drug: 3 drug regimen: Tenofovir DF and Emtricitabine; Ritonavir-boosted Atazanavir;   Drug: Ritonavir, Atazanavir, Truvada
17 Recruiting Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: Losartan;   Drug: Placebo
18 Terminated Mild Neurocognitive Disorder in HIV Infection of the Brain
Condition: HIV-Associated Cognitive Motor Complex
Intervention:
19 Completed Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya
Conditions: HIV;   Malnutrition
Intervention: Other: Multi-sectoral agricultural intervention
20 Completed An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulation (VF) of tenofovir 1% gel;   Drug: Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel;   Radiation: Radiolabeling of study drugs and semen

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.